Hexoskin in South San Francisco for the 3rd Annual Clinical Trial Innovation Summit 2026 at Genentech

October 09, 2026

Hexoskin is proud to sponsor the 3rd Annual Clinical Trial Innovation Summit this October 13th hosted at Genentech in South San Francisco.

Over the past 10 years, the research community has invested heavily in AI, digital biomarkers, digital twins, decentralized trials, tokenization, and digital health technologies. We've learned when these technologies are useful and valuable, and when they're not. Now it's time to make them work at scale, across sites, populations, in ways that patients and sponsors both feel.

The gap between a successful pilot and routine, patient-centered practice is called the “valley of adoption” and is the focus of this year's summit. More than 25 speakers and over 200 senior leaders in clinical research, operations, and trial design will look at where innovation is delivering measurable value, where implementation still stalls, and how good approaches can be scaled responsibly.

What crossing the valley looks like from our side

At Hexoskin, we’ve learned that adoption depends less on what a technology can measure and more on how we operationalize it in a successful trial. Here’s what we bring to sponsors working to close that gap:

• A dedicated team that supports your study from protocol design to biostatistical analysis. More than sensors and a software platform for managing data collection across sites and cohorts of patients, our team support you through all the steps of a trial, include site training, tech support, and logistics.
  
• Only FDA-cleared wearable for both cardiac and respiratory markers. The Hexoskin Smart Shirt records 3-lead ECG, dual-channel respiratory inductance plethysmography (RIP), and 3-axis accelerometry, all from one comfortable garment. Respiratory patterns are rarely captured continuously outside the lab, and Hexoskin has pioneered their use for many disease categories.
  
• 112 digital biomarkers from a single device. These range from heart rate variability and breathing patterns to gait, sleep, and physical activity. Sponsors can choose the endpoints that matter for their program without adding devices, or burden, for participants.
• Endpoints and early signals across therapeutic areas. Hexoskin data supports research in neurology, rare diseases, and respiratory disease, among other areas. In rare disease especially, a small population means every data point and patient reported outcome is especially valuable.
• A growing body of evidence. Hexoskin has been used in more than 350 scientific publications. You can browse the literature by field in our online paper database.

Contact our team for more information.